Faithful to their parent imidazotetrazines, MTIC was active only against vector control GBM cell lines; whereas, N3P triazene showed equi-potency (GI50 < 35 μmol/L) in GBM cell lines irrespective of MGMT status. This evidence concerns the gene MGMT and glioblastoma.